The large, cylindrical iron column on the side of the Leeds-Liverpool Canal at Eanam Wharf in Blackburn, tapering upwards, ...

One of the perennial challenges of building robots is minimizing the size and weight of drive systems while preserving power.

The first step in a 12-step program is for the addict to admit that they have a problem, because most addicts are in denial about their addictions. And, as my clinical supervisor observed when I was ...

Arcturus Therapeutics sued AbbVie and Capstan Therapeutics for allegedly misusing its lipid nanoparticle (LNP) delivery technology after former staff joined Capstan. The case spotlights the high ...

Scientists in the laboratory of Weiguo Cui, Ph.D., professor of Pathology in the Division of Experimental Pathology, have identified novel molecular mechanisms that help specialized T-cells maintain ...

Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform ...

(RTTNews) - AbbVie (ABBV) has completed its acquisition of Capstan Therapeutics, bringing the biotech company under its umbrella. Capstan's lead program, CPTX2309, is a Phase 1 tLNP-based therapy that ...

I’ve been going down a gaming handheld rabbit hole for the last few years, spurred on by the Steam Deck back in 2022. While these PC handhelds definitely existed before that – usually with laptop ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is raising its 2025 earnings guidance for the ...

Capstan Therapeutics — a biotechnology company pioneered by Penn researchers — was acquired by AbbVie in $2.1 billion deal. Capstan, which specializes in CAR-T therapies for autoimmune disorders, ...